Orthofix International Introduces FUSION(R) XT High Performance Knee Brace with New AirTech(TM) Innovation

August 16, 2010

BOSTON, Aug 16, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) (the Company) announced today that its Sports Medicine Division, Breg, has launched the FUSION(R) XT knee brace with its innovative new AirTech(TM) system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.

In addition to AirTech innovation, the FUSION XT brace also includes pivot-point strap tabs that are longer, flexible and more durable. These new pivot-points enable patients to independently position the straps in order to provide a superior fit.

"The enhanced FUSION XT brace provides significant advancements in performance and durability for high impact sports like football," said Alan Milinazzo, President and CEO of Orthofix. "The AirTech system represents our continued focus on making the FUSION line of braces the standard in patient comfort, fit and compliance, and also demonstrates Orthofix's ongoing commitment to product innovation."

The U.S. market for ligament braces is estimated to be approximately $167 million in 2010, with an annual growth rate of 3.8%.

Available now on the FUSION XT Ligament brace, the Company plans to also incorporate the AirTech system into its FUSION and FUSION Women's braces.

For more information about Breg's portfolio of products, including FUSION braces, visit www.orthofix.com or www.breg.com.

About Orthofix

Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages-helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including BREG, Inc. and via partnerships with other leading orthopedic product companies. In addition, Orthofix collaborates with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and The University of Medicine and Dentistry of New Jersey. For more information about Orthofix, please visit www.orthofix.com.

SOURCE: Orthofix International

Orthofix International, N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations

Copyright Business Wire 2010